Adding MS drug to targeted cancer therapy may improve glioblastoma outcomes

06:26 EDT 9 Aug 2019 | ecancermedicalscience

Glioblastoma is an aggressive form of brain cancer that infiltrates surrounding brain tissue, making it extremely difficult to treat with surgery. Even when chemotherapy and radiation successfully destroy the bulk of a patient's glioblastoma cells, they...

More From BioPortfolio on "Adding MS drug to targeted cancer therapy may improve glioblastoma outcomes"